Assessment Of 10-Year Risk Of Developing A Major Cardiovascular Event In Patients Attending A Hospital For The Treatment Of Other Disorders
Int J Pharm Pharm Sci
;
2020 Jul; 12(7): 66-73
Article
| IMSEAR
| ID: sea-206127
ABSTRACT
Objective:
To assess the individual’s predicted risk of developing a CVD event in 10 y using risk scores among persons with other disorders/diseases.Methods:
This is a cross-sectional observational study conducted for a period of 6 mo among 283 subjects. Total risk was estimated individually by using Framingham Risk Scoring Algorithm and ASCVD risk estimator.Results:
According to Framingham Risk score the prevalence of low risk (<10%) identified as 67.84% (192), followed by intermediate risk (10%-19%), 19.08% (54), and high risk (≥20%) 13.07% (37). By using ASCVD Risk estimator, risk has reported in our study population was low risk (<5%) is 48.76% (138), borderline risk (5-7.4%) is 13.07% (37), intermediate risk (7.5-19.9%) is about 25.09% (71), high risk (>20%) is about 13.07% (37).Conclusion:
In this study burden of CVD risk was relatively low, which was estimated by both the Framingham scale and ASCVD Risk estimator. Risk scoring of individuals helps us to identify the patients at high risk of CV diseases and also helps in providing management strategies.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Type of study:
Etiology study
/
Observational study
/
Prognostic study
/
Risk factors
Journal:
Int J Pharm Pharm Sci
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS